
JAGX vs VBIO
$JAGX vs $VBIO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
JAGX vs VBIO: trend, levels and the market
One year to 2026-11-13, against the S&P 500 (+6%). Split-adjusted daily closes.
- ·Neither kept up with the market over the past year: JAGX -99.7% and VBIO -97.9%, against the S&P 500 at +6%.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
JAGX vs VBIO: the quick read
- ·VBIO is the larger company by market cap ($1M vs $973,029).
- ·JAGX has been more active on our scanner (52 vs 4 alerts in 30 days).
- ·VBIO has the smaller float (2.0M vs 2.3M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·JAGX draws far more of our scanner's attention, 52 unusual-volume alerts in 30 days against 4, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 14% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
Objective differences only. Not investment advice.
Watching JAGX or VBIO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing JAGX and VBIO on TheDesperateTrader.
- Is JAGX or VBIO the better stock?
- "Better" depends on your goal, and these two are not alike. VBIO is the larger company by market cap ($1M vs $973,029). JAGX has been more active on our scanner (52 vs 4 alerts in 30 days). VBIO has the smaller float (2.0M vs 2.3M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between JAGX and VBIO?
- The differences that matter: they are not in the same business - JAGX is pharmaceutical preparations and VBIO is pharmaceutical preparations; they are similar in size ($973,029 vs $1M); they trade at very different share prices ($0.43 vs $0.54); JAGX sits at 0% of its 52-week range against 10% for VBIO; our scanner flagged JAGX 52 times in the last 30 days against 4 for VBIO. Everything above is measured from the latest completed session and SEC filings.
- Which of JAGX and VBIO is more active right now?
- Right now JAGX is at about 0.2x its normal volume and VBIO is at about 0.0x, so JAGX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is JAGX or VBIO in the stronger trend?
- JAGX is below its 50-day average of $4.09 and below its 200-day average of $98.68; VBIO is below its 50-day average of $1.66. VBIO leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading JAGX or VBIO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.